ImmunityBio, Inc. (IBRX)
IBRX price $8.64 -0.13 -1.48%
- Ticker
- IBRX
- Price
- $8.64
- Change
- -0.13 -1.48%
- Market cap
- $9.16B
- P/E
- -8.87
- Forward P/E
- 16.00
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 70
ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California. The company is focused on developing groundbreaking therapies and vaccines designed to treat a wide array of cancers and infectious diseases. Its innovative approach relies on a comprehensive suite of immunotherapy and cell therapy platforms. These advanced technologies include novel antibody-cytokine fusion…